About Dr. Peng Chenghong
Dr. Peng Chenghong (彭承宏) is one of China's foremost hepatobiliary and pancreatic surgeons and a nationally recognized authority on robotic and minimally invasive surgery for liver, bile duct, and pancreatic diseases. He serves as Director of the Department of Hepatobiliary and Pancreatic Surgery at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, and holds the title of Chief Physician and Professor.
Dr. Peng is particularly distinguished as one of China's leading pioneers of robotic-assisted hepatopancreatobiliary (HPB) surgery — a field where his technical innovations and high-volume experience have placed Ruijin Hospital among the top robotic HPB surgery centers in Asia. His expertise spans the full spectrum of liver, bile duct, and pancreatic surgery, from complex liver resections and bile duct reconstructions to pancreaticoduodenectomy (Whipple procedure) and distal pancreatectomy, all performed with minimally invasive precision.
International patients with liver cancer, pancreatic cancer, bile duct disease, or benign HPB conditions seeking surgical care in China consistently identify Dr. Peng as one of the country's top HPB surgeons for both primary surgical treatment and second opinions on complex cases.
Professional Positions and Affiliations
- Director, Department of Hepatobiliary and Pancreatic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Chairman, Robotic Surgery Committee, Chinese Society of Surgery
- Vice Chairman, Hepatobiliary Surgery Committee, Chinese Society of Surgery
- Editorial Board Member: Surgical Endoscopy, Journal of Hepato-Biliary-Pancreatic Sciences, Chinese Journal of Surgery
- Fellow, International Hepato-Pancreato-Biliary Association (IHPBA)
- Fellow, Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
Specialties and Clinical Expertise
- Robotic HPB Surgery — robotic-assisted hepatectomy, pancreaticoduodenectomy (Whipple), distal pancreatectomy, bile duct resection and reconstruction; one of China's highest-volume robotic HPB surgeons
- Liver Surgery — anatomic and non-anatomic hepatectomy for hepatocellular carcinoma (HCC), liver metastases, and intrahepatic cholangiocarcinoma; laparoscopic and robotic approaches; liver-sparing resection and staged hepatectomy (ALPPS)
- Pancreatic Surgery — pancreaticoduodenectomy (Whipple procedure), pylorus-preserving Whipple, distal pancreatectomy with splenectomy, total pancreatectomy, and central pancreatectomy for pancreatic cancer, IPMN, and neuroendocrine tumors
- Bile Duct Surgery — hilar cholangiocarcinoma (Klatskin tumor) resection with biliary reconstruction, common bile duct exploration, and choledochal cyst excision
- Gallbladder Cancer Surgery — radical cholecystectomy with lymphadenectomy and bile duct resection for advanced gallbladder cancer
- Benign HPB Disease — laparoscopic cholecystectomy, bile duct stone surgery, hepatic cyst fenestration, and liver abscess drainage
- Liver Transplantation Surgery — living donor and deceased donor liver transplantation; coordination with the transplant team
- Neoadjuvant and Conversion Therapy — surgical planning after neoadjuvant chemotherapy or targeted therapy for borderline resectable pancreatic cancer and initially unresectable liver tumors
Academic and Research Contributions
Dr. Peng Chenghong has published over 220 peer-reviewed papers in leading international surgical journals, with a particular focus on robotic HPB surgery outcomes, minimally invasive pancreaticoduodenectomy, and the surgical management of hilar cholangiocarcinoma. His landmark series on robotic Whipple procedures — demonstrating safety and oncological equivalence to open surgery with significantly reduced blood loss and hospital stay — has been widely cited and has contributed to the global adoption of robotic pancreatic surgery.
He chairs the Robotic Surgery Committee of the Chinese Society of Surgery and has been instrumental in developing national standards and training programs for robotic HPB surgery in China. He is a regular invited speaker at IHPBA, SAGES, and the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) congresses.
Hospital: Ruijin Hospital HPB Surgery Department
Under Dr. Peng's leadership, Ruijin Hospital's HPB Surgery Department operates:
- A dedicated Robotic Surgery Program with multiple da Vinci Xi systems for HPB procedures
- A Multidisciplinary HPB Tumor Board meeting weekly, integrating surgery, medical oncology, interventional radiology, and hepatology
- A Liver Transplantation Program with both living donor and deceased donor capability
- A Pancreatic Cancer Multidisciplinary Clinic for borderline resectable and locally advanced cases
- Close collaboration with the Interventional Radiology Department for preoperative portal vein embolization and TACE
Why International Patients Choose Dr. Peng Chenghong
- China's robotic HPB surgery pioneer — Chairman of China's national robotic surgery committee
- Highest-volume robotic Whipple surgeon in China — unmatched experience in minimally invasive pancreatic surgery
- Complex liver surgery expertise — ALPPS, staged hepatectomy, and hilar cholangiocarcinoma resection
- IHPBA and SAGES Fellow — internationally credentialed and aligned with global HPB surgery standards
- Conversion surgery capability — surgical planning after neoadjuvant therapy for initially unresectable tumors
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Ruijin Hospital, 197 Ruijin Er Road, Huangpu District, Shanghai
- Appointment Lead Time: 2″4 weeks for elective consultations; urgent cases expedited through CMCS
- Languages: Mandarin Chinese; English interpretation provided by CMCS
- Pre-consultation: Overseas CT, MRI, PET-CT, and pathology reports can be reviewed remotely through CMCS before travel
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking HPB surgery with Dr. Peng Chenghong at Ruijin Hospital. Our services include priority appointment booking, medical record and imaging translation, remote pre-consultation review, on-site interpretation, accommodation coordination, insurance liaison, and post-surgical follow-up with your home country oncologist or surgeon.
📧 Contact us: contract@medicalsh.com
🌐 medicalsh.com
0 comentarios